Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain	Neoplasms by Site, brain disorder, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder	Recruiting	Phase 2	2026-09-22		NCT07470606

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
The University of Texas Health Science Center at San Antonio	127

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Mays Cancer Center, UT Health San Antonio	San Antonio	United States	5

Clinical trials